(FocalFinder/iStock/Getty Images Plus) Researchers have identified a previously unknown neurodevelopmental disorder ...

AI algorithms that can identify which patients are most likely to benefit from a drug recently backed for NHS use as a colorectal cancer (CRC) therapy have been developed by scien ...

Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...

Key opportunities in the Bardet-Biedl syndrome market include growing awareness and uptake of IMCIVREE, an FDA-approved drug, and the lack of emerging competitors. The US leads in market size compared ...

Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.

When Ben Sasse announced last December that he had been diagnosed with Stage 4 pancreatic cancer, he called it a death ...

Scientists have achieved a world first by loading a complete genome onto a quantum computer – a major step towards using ...

The former senator wants to heal the America he’s leaving behind.

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...

April 9, 2026 - By Denise Heady - UCLA scientists have developed a simple and cost-effective blood test that, in early ...

Explore emerging screening technologies in drug discovery. Enhance laboratory workflows with advanced models, CRISPR, and ...